author-photo

David Aguiar

24

Papers

154

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data

2021 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (0)
P76.42 OsimertinibTreatment in Non-Small Cell Lung Cancer (NSCLC) EGFR-T790M+. Activity in Patients with CNS Metastases. OSIREX

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Author response for "Long‐Term Follow‐Up of Patients with Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Report from the Spanish Lymphoma Oncology Group"

2020
Show All
- Source
- Cite
- Save
Citations (0)
Osimertinib in Advanced EGFR-T790M Mutation-positive Non-small Cell Lung Cancer Patients Treated Within the Special Use Medication Program in Spain. OSIREX-spanish Lung Cancer Group

2020
Show All
- Source
- Cite
- Save
Citations (2)
Long‐Term Follow‐Up of Patients with Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Report from the Spanish Lymphoma Oncology Group

2020 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.

2020 Cancer Epidemiology
Show All
- Source
- Cite
- Save
Citations (6)
889MO Long-term follow-up of patients with nodular lymphocyte predominant Hodgkin lymphoma: A report from the Spanish Lymphoma Oncology Group

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: the ROSING Study

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (34)
P2.10-02 Smoking Habit in Lung Cancer in Spain

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group

2018 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)